Cationic liposomes with plasmid DNA influence cancer metastatic capability
Takahide Ota1, Masayo Maeda, Masaaki Tatsuka
1Division of Cancer Research, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan.
Background:
Cancer gene therapy is now being developing to provide new strategies for the treatment of human tumors. Cationic lipids represent one of the powerful mediators for DNA delivery. The liposome-plasmid DNA complex itself is known to inhibit tumor cell growth, but other effects on cancer cell behaviors have not been reported so far.
Materials And Methods:
Six commercially available cationic liposomes complexed with plasmid DNA were applied to cancer cells and their metastatic potentials were measured.
Results:
The liposome-plasmid DNA complexes affected metastatic capability in three different ways: TM-TPS:DOPE and DOTAP:DOPE had no effect on metastatic capability; a suppressive effect was observed in DOSPA:DOPE and DMRIE:cholesterol; while an augmentative effect was observed in DOTMA:DOPE and Effectene. These effects are likely to be DNA sequence independent, because different plasmids have the same effects.
Conclusion:
Liposome-plasmid DNA complexes influence cancer metastasis capability, dependent upon the cationic liposome formulations.
Insights
Cationic liposome-plasmid DNA complexes impact cancer metastasis differently based on formulation. Some formulations suppress metastasis, while others enhance it, offering new insights for cancer gene therapy.
Area of Science:
- Biotechnology
- Cancer Research
- Gene Therapy
Background:
- Cancer gene therapy is an emerging treatment strategy.
- Cationic lipids are key mediators for DNA delivery in gene therapy.
- Liposome-plasmid DNA complexes show potential for tumor inhibition, but their effects on cancer cell metastasis are largely unexplored.
Purpose of the Study:
- To investigate the impact of various cationic liposome-plasmid DNA complexes on cancer cell metastatic potential.
- To determine if liposome formulation influences the metastatic capability of cancer cells.
Main Methods:
- Six commercially available cationic liposomes were complexed with plasmid DNA.
- These complexes were applied to cancer cells.
- The metastatic potentials of the treated cancer cells were measured.
Main Results:
- Cationic liposome-plasmid DNA complexes exhibited varied effects on metastasis.
- TM-TPS:DOPE and DOTAP:DOPE showed no effect.
- DOSPA:DOPE and DMRIE:cholesterol suppressed metastasis, while DOTMA:DOPE and Effectene augmented it.
- Observed effects were independent of DNA sequence.
Conclusions:
- Liposome-plasmid DNA complexes significantly influence cancer metastasis.
- The effect on metastasis is dependent on the specific cationic liposome formulation used.
- Findings highlight the importance of cationic liposome choice in cancer gene therapy strategies.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia


